Designing antibodies to think before they bind
Standard antibody therapies bind their target and trigger a response.…
Standard antibody therapies bind their target and trigger a response. But what if the real breakthrough is designing antibodies that first recognise context before they act? This article looks at how bispecifics are becoming smarter, more selective and more precise.